Ro

@serenawilliams is on Ro! There are few people in the world with more willpower than Serena. She trained hard after having kids but her body didn’t respond the same way. She turned to Ro to reach her goals. youtube.com/watch?v=_MAYscxx…

@ZReitano sat down with @Hilarx at @BusinessInsider for his first in-depth interview on RobinAI, Ro's new AI agent: businessinsider.com/exclusiv…

Megan Fox is Ro Sparks! Introducing our first ever celebrity campaign for our innovative 2-in-1 treatment for ED. All men should feel confident seeking support and exploring treatment for better sex. And what better person to help “spark” that conversation than Megan Fox? Check out our new Ro Sparks 🔥 campaign! youtube.com/watch?v=N0UBtprx…

Welcome back, @serenawilliams. We’ll be cheering you on every step of the way. 🎾

With Wegovy HD (7.2 mg) now available on Ro, eligible patients can lose more weight than ever on Wegovy. Ro’s Body Program supports ongoing, personalized care, with a comprehensive formulary, spanning options across form factor, dose, and price to meet individual needs.

We’re announcing lower prices for our Ro Body Membership! Patients can save up to 50% ($900 per year) off when choosing an annual membership plan. The same exact membership, just at lower prices (medication cost separate). ro.co/news/multi-month-membe…

Now on Ro: Foundayo from @EliLillyandCo—the newest GLP-1 pill. This treatment offers patients a flexible, daily pill option that’s delivered directly to their door, at the best cash price. ro.co/press/foundayo/

Zepbound KwikPen now on Ro: a simpler way to take the most effective GLP-1. Four weekly shots in a single pen—no vials or syringes. We’ll continue expanding access to the latest innovations to make high-quality care easier for patients: ro.co/press/zepbound-kwikpen…

Introducing new Wegovy savings on Ro—saving patients up to $1,200/year. With @novonordisk, we’re offering the lowest available cash prices and expanding access to effective, FDA-approved GLP-1s, with more ways to save on Ro’s Body membership coming soon. ro.co/press/wegovy-savings-o…

We’re making our Super Bowl debut next week—featuring @serenawilliams. In the ad, Serena shares how being on Ro has helped her feel her best, with the benefits she’s experienced going well beyond weight loss, including less joint stress and steady blood sugar. Here’s a first look at the ad. Serena’s healthier on Ro. Supported on Ro.

Ro is collaborating with @Amgen to study insurance coverage of GLP-1s. Our joint research will spotlight which patients have coverage, where gaps in coverage exist, and how to expand access to treatment as the next generation of GLP-1s come to market. ro.co/press/amgen-collaborat…

Introducing the Wegovy pill—launched on Ro. By working directly with @novonordisk , we are giving patients nationwide access to this innovative new treatment Day 1 and with seamless delivery to their doors at the best cash price. ro.co/press/wegovy-pill/

Patients come to Ro to reach their health goals—and our study in Obesity (@ObesitySociety) shows that they’re successful. Weight loss and safety outcomes were consistent with those in semaglutide clinical trials, losing 16.6% of their weight in 68 weeks. ro.co/press/68-week-outcomes…

Curious if your insurance covers GLP-1s? Ro’s Insurance Coverage Checker has helped hundreds of thousands. Now, we're revealing key insights in our new report on GLP-1 access. Read the full report: ro.co/weight-loss/coverage-c…

Ro is working with @EliLillyandCo! Through a first-of-its-kind integration with LillyDirect, Zepbound single-dose vials are now available through Ro – offering a seamless obesity care experience bringing together telehealth, lab, and pharmacy services. cnbc.com/2024/12/11/ro-to-of…

Patients come to Ro for the care they need to live happier, more fulfilled lives. Today, we’re sharing research highlighting the many ways accessing obesity care through Ro can change lives: ro.co/weight-loss/quality-of…

Tune in at 2:50PM ET to catch Ro CEO, @ZReitano chat with @Axios' @danprimack about the impact of GLP-1s on the healthcare system and beyond at #AxiosBFD! youtube.com/watch?v=K5_vjR6S…

We appreciate the Senate HELP Committee's focus on expanding access to GLP-1 medications, such as Ozempic and Wegovy, for more patients. Beyond those paying cash or without insurance, our data shows that even patients with coverage can face high costs.

Ro has conducted benefits verifications for patients nationwide. Our insights reveal that there is still so much more to be done to help patients access high-quality obesity care – from increasing ins. coverage to removing roadblocks to care. #ObesityCareNOW

How can people maintain muscle while on GLP-1s? Our team and advisors, @BevTchangMD & Dr. David Allison, delve into the relationship between weight loss and muscle mass + strength, plus share insights on maintaining both with lifestyle interventions. ro.co/perspectives/glp1s-mus…